Advertisement

Topics

A New Drug for Atrial Fibrillation Starts Human Testing in Europe

08:02 EDT 14 Mar 2018 | Labiotech.eu

Update (14/03/2018): Acesion Pharma has started a Phase I clinical trial at the Centre for Human Drug Research (CHDR) in the Netherlands. The trial will test AP30663, a treatment for atrial fibrillation that the company believes has the potential to ...

This awesome article A New Drug for Atrial Fibrillation Starts Human Testing in Europe appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: A New Drug for Atrial Fibrillation Starts Human Testing in Europe

NEXT ARTICLE

More From BioPortfolio on "A New Drug for Atrial Fibrillation Starts Human Testing in Europe"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...